| Ytd | -68.32% | |
| 1y | -87.26% |
| Open | 2.76 | Prev Close | 2.94 | Low | 2.58 | High | 3.10 | Mkt Cap | 2.18M |
| Vol | 1.29M | Avg Vol | 1.13M | EPS | -30.50 | P/E | N/A | Forward P/E | -1.01 |
| Beta | 1.93 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.35 | 200-d Avg | 8.21 | 1yr Est | 20.00 |
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announce
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
Virax Biolabs Group Limited shares rose 17.36% after hours following heavy intraday gains and disclo
US stocks lower as Nasdaq falls 200 points, Dow down 0.04% and S&P 500 down 0.37%. Energy shares
Bloom Energy (BE) rose in pre-market trading as it announces expanded partnership with Oracle (ORCL)
US stocks fall, Dow down 350 points, tech up 1.2%. Goldman Sachs beats earnings, oil up 7.1%, Europe
IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline
Shares of Virax Biolabs Group are soaring Tuesday after it secured several regulatory certifications
Virax Biolabs Group Limited (NASDAQ:VRAX) ("Virax" or the "Company") today announced